Dr Marla Lipsyc-Sharf discusses how to best manage the challenging side effects associated with PIK3CA and mTOR Inhibitors to optimize patient care.
Managing the side effects in patients being treated for metastatic breast cancer can be challenging. Recently, Marla D.
Lipsyc-Sharf, MD, a breast medical oncologist and health sciences clinical instructor of medicine in the Division of Hematology/Oncology at the University of California, Los Angeles, David Geffen School of Medicine, spoke with Medscape about managing side effects of phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha and mammalian target of rapamycin inhibitors.
Metastatic Breast Carcinoma COE Metastatic Breast Cancer COE MBC COE Advanced And Metastatic Breast Cancer Center Of E Advanced Breast Cancer Metastatic Breast Carcinoma Metastatic Breast Cancer MBC Mbc Advanced BC Metastatic BC Metastatic Breast Cancer (MBC) MBC - Metastatic Breast Cancer Dermatitis Patient Safety Adverse Effects Side Effects
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
MACE Risk Similar Across Biologic Classes Used to Treat Psoriasis, Psoriatic ArthritisA retrospective analysis shows no difference in major adverse cardiovascular events (MACE) between TNF inhibitors, IL-17 inhibitors, IL-23 inhibitors, and IL-12/IL-23 inhibitors.
Read more »
Psoriatic Arthritis Risk Similar With IL-23 and IL-12/23 InhibitorsA study found no significant differences in the risk for PsA among patients with psoriasis treated with interleukin (IL)-23 inhibitors and those treated with IL-12/23 inhibitors.
Read more »
Discovery suggests opportunity to improve effectiveness of KRAS inhibitors against pancreatic cancerResearchers discovered a new mechanism of resistance to KRAS inhibitors that suggests an opportunity to make the treatment more effective.
Read more »
Research shows protein isoform inhibitors may hold the key to making opioids saferResearchers have identified a new way to make opioids safer, increasing the pain-relieving properties of opioids while decreasing unwanted side effects through the spinal inhibition of a Heat shock protein 90 isoform.
Read more »
How Cancer Immunotherapy Checkpoint Inhibitors WorkI am a scientist, businessman, author, and philanthropist. For nearly two decades, I was a professor at Harvard Medical School and Harvard School of Public Health where I founded two academic research departments, the Division of Biochemical Pharmacology and the Division of Human Retrovirology.
Read more »
Chemistry inspired by one-pot cooking helps achieve optimal reaction conditionsPeople have long dreamed of developing materials to circumvent the challenges of daily life. Ideally, one could capitalize on a combination of the features of different materials, profiting from their advantages while avoiding the disadvantages.
Read more »